Navigation Links
Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
Date:11/26/2008

ORLANDO, Fla., Nov. 26 /PRNewswire/ -- Valensa International (Orlando, USA) and Parry Nutraceuticals (Division of E.I.D. Parry (India) Ltd., Chennai, India), as part of a growth strategy for both companies, have joined forces to usher in the next generation of high-performance nutritional products from plant-derived sources for the condition-specific dietary supplement, functional food and fortified beverage sectors. EID Parry acquired a 48% strategic stake in U.S. Nutraceuticals doing business as Valensa International. Valensa's "Direct to Marketers" product development and business strategy will be expanded under a new management team led by Valensa's President, Dr. Rudi E. Moerck, which includes executives from both companies. With the Valensa investment, Parry becomes a marketing partner and a strategic source of botanical materials and technology for new and existing Valensa products in the fast-growing areas of Omega-3 Essential Fatty Acids (ALA, EPA and DHA); phycocyanins and carotenoids including astaxanthin, lycopene, lutein, zeaxanthin; and others. The new arrangement will strengthen Valensa's ability to market its science-based products globally. Current areas of co-marketing between the companies include astaxanthin and Valensa's patented SpiruZan(TM), a Spirulina/Astaxanthin product co-launched by the two companies at Natural Products Expo East in Boston and HI Europe in Paris.

According to Dr. Rudi E. Moerck, the companies have the same philosophies on sustainable natural product production and focus on natural ingredients made using environmentally responsible technology such as Valensa's organic-certified supercritical carbon dioxide extraction plant in Florida, USA. "Parry Nutraceuticals shares Valensa International's commitment to creating the highest-quality products based on the best available science for the condition-specific human health and nutrition market," he said. "Parry Nutraceuticals is one of the leading producers of ultra-high-quality raw materials including organic Spirulina and carotenoids like beta carotene, astaxanthin, lutein and tomato lycopene. Our cooperative new product development work with Parry will allow us to accelerate our new product development efforts to deliver some of the most exciting new products to the market," he added.

Two Leaders Working Together

Valensa and Parry recently introduced a new dietary supplement, SpiruZan(TM) -- a synergistic complex of micro-algae-based organic Spirulina and Astaxanthin in a small, easy-to-swallow 500 mg caplet presentation. SpiruZan combines the well-known nutritional properties of organic Spirulina with the superior antioxidant properties of Astaxanthin to deliver a "brain+body" supplement that offers enhanced protection from both dietary and environmental stress factors. SpiruZan is now available, providing 1 mg astaxanthin in an organic Spirulina serving. Spirulina product line extensions are also planned.

Parry Nutraceuticals produces the only GRAS-certified Spirulina that is also certified under USDA NOP, OCIA-IFOAM, Naturland and ECOCERT organic standards. Valensa's ingredients are manufactured using the company's DeepExtract(TM) High Pressure Supercritical CO2 Extraction and O2B(TM) Peroxidation Blocker technology, yielding more of the micronutrients contained in natural botanical materials and protecting both products and people from the problems associated with oxidation and rancidification.

    For further information, contact:

    Dr. Rudi E. Moerck, President
    Voice: 210-632-0695
    Fax: 352-483-2095

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Valensa International
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
2. International Formula Council Statement on Melamine and Infant Formulas
3. Pulmonary Hypertension Treated with Stem Cells : International Medical Team Announces Patient Results in Adult Stem Cell Clinical Study for Pulmonary Hypertension
4. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
5. Lights Out For Bed Bugs as "BEST YET" Cedar Oil Solution Solves International Bed Bug Dilemma
6. AirMed International wins Air Ambulance of the Year for Second Consecutive Year
7. Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.
8. Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013
9. Epocrates Offers International Market Research Panel
10. Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab
11. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s Dream ... $10,000 to University of Chicago to support ovarian cancer research being conducted by Dr. ... to support a promising young investigator from Dr. Lengyel’s lab at the University of ...
(Date:2/10/2016)... ... February 10, 2016 , ... Sherly ... for a series of therapeutic sessions to help Los Angeles-area actors cope with ... their lives. The series, known as “Mindfulness for Actors and Artists,” has been ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... 10, 2016 , ... As part of its ongoing series of aquatic therapy ... webinar features a dynamic expert and thoughtful presentation to give attendees a better sense ... Both events are free to attend, but registration is required. , Rehabilitation ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- Indiso ltd , a medical technology company ... respiratory diseases announced today positive results in its clinical ... patients show improvements in respiratory functions and other clinical ... Upper and lower respiratory tract diseases and allergy ... reached epidemic level. Increasing number of studies however show ...
(Date:2/10/2016)... http://www.researchandmarkets.com/research/rp4pg8/molecular ) has ... Diagnostics Reports Bundle" report to their ... announced the addition of the "Molecular ... offering. --> Research and Markets ... of the "Molecular Diagnostics Reports Bundle" ...
(Date:2/10/2016)...  Cepheid (Nasdaq: CPHD ) today announced ... President and Chief Operating Officer, has been promoted ... Officer.  In his new capacity, Mr. Kocmond,s responsibilities ... Operations in addition to Manufacturing Operations, Engineering, Technical ... to report to John Bishop , Cepheid,s ...
Breaking Medicine Technology: